Russell Investments Group
CALA

Russell Investments Group’s Calithera Biosciences, Inc CALA Stock Holding History

Russell Investments Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47
Closed -$2K – 3155
2021
Q3 		$2K Hold
47
– – ﹤0.01% 3020
2021
Q2 		$1K Sell
47
-4,284
-99% -$188K ﹤0.01% 3195
2021
Q1 		$209K Sell
4,331
-503
-10% -$29.3K ﹤0.01% 2814
2020
Q4 		$475K Sell
4,834
-827
-15% -$72.5K ﹤0.01% 2452
2020
Q3 		$389K Hold
5,661
– – ﹤0.01% 2507
2020
Q2 		$597K Buy
5,661
+496
+10% +$58.9K ﹤0.01% 2316
2020
Q1 		$458K Buy
5,165
+5,120
+11,378% +$610K ﹤0.01% 2219
2019
Q4 		$5K Buy
+45
New +$3.38K ﹤0.01% 3066
2018
Q4 		– Sell
-260
Closed -$27K – 3072
2018
Q3 		$27K Sell
260
-10
-4% -$952 ﹤0.01% 2895
2018
Q2 		$27K Buy
+270
New +$30.6K ﹤0.01% 2866

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Russell Investments Group's CALA Position: Q4 2021 in Review

Russell Investments Group sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 47 shares — an estimated $2K sold.

Russell Investments Group first reported a position in CALA in Q2 2018 and held it in 10 quarters. The position peaked at $597K in Q2 2020. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

  • Russell Investments Group reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
  • Russell Investments Group sold 47 Calithera Biosciences, Inc shares in Q4 2021, an estimated $2K.
  • Russell Investments Group first reported a position in Calithera Biosciences, Inc in Q2 2018 and held it in 10 quarters.
  • Russell Investments Group's Calithera Biosciences, Inc position peaked at $597K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Russell Investments Group's 13F filing for Q4 2021, filed 21 Jan 2022.